The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Investigation on the Efficacy of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From Vulvovaginal Dryness
Official Title: Multicentric Study on the Application of WO 2085 Moisturising Cream for Breast Cancer Patients Suffering From the Symptoms of Vulvovaginal Dryness
Study ID: NCT03593122
Brief Summary: The aim of the study is to gain further experience with regard to the performance of the medical device WO2085 Moisturising Cream for breast cancer patients undergoing chemotherapy or treatment with anti-oestrogens / aromatase inhibitors
Detailed Description: The goal of this application study was to answer the question as to whether the application of WO2085 Moisturising Cream for breast cancer patients undergoing chemotherapy or treatment with anti-oestrogens / aromatase inhibitors can result in an improvement in the subjective symptoms and objective diagnoses of vulvovaginal dryness while also ensuring good tolerability.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Axel Gerick, Aachen, , Germany
Sibylle Kaßpohl, Alzenau, , Germany
Jörg Schilling, Berlin, , Germany
Axel Widing, Berlin, , Germany
Alexandra Coumbos, Berlin, , Germany
Amin Mortazawi, Darmstadt, , Germany
Kathrin von Ardenne, Dresden, , Germany
Joachim Larbig, Fulda, , Germany
Nidal Gazawi, Leipzig, , Germany
Elke Wierick, Lohsa, , Germany
Dagmar Guth, Plauen, , Germany
Wolfgang Clemens, Stolberg, , Germany
Carsten Hielscher, Stralsund, , Germany
Christopher Wolf, Ulm, , Germany
Heidi Massinger-Biebl, Waldkirchen, , Germany
Klaus Doubek, Wiesbaden, , Germany
Anja Obermeyer, Würselen, , Germany
Name: Prof. Christoph Abels, MD, PhD
Affiliation: Dr. August Wolff GmbH & Co. KG Arzneimittel
Role: STUDY_DIRECTOR